Improved Survival of Patients with Pulmonary Arterial Hypertension with BMPR2 Mutations in the Last Decade

Am J Respir Crit Care Med. 2016 Jun 1;193(11):1310-4. doi: 10.1164/rccm.201601-0158LE.
No abstract available

MeSH terms

  • Adult
  • Antihypertensive Agents / therapeutic use*
  • Bone Morphogenetic Protein Receptors, Type II / genetics*
  • Epoprostenol / therapeutic use*
  • Female
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Hypertension, Pulmonary / genetics*
  • Male
  • Mutation / genetics*
  • Survival Analysis
  • Treatment Outcome

Substances

  • Antihypertensive Agents
  • Epoprostenol
  • BMPR2 protein, human
  • Bone Morphogenetic Protein Receptors, Type II